Molecular assays begin with release, preservation, and purification of the target nucleic acid. Enzymes may support cell-wall disruption, protein digestion, nuclease-based host depletion, viscosity reduction, or cleanup of unwanted nucleic-acid species. The correct choice depends on organism, specimen, target type, extraction chemistry, and downstream assay.
Proteinase K digests proteins and can help release nucleic acids or reduce nuclease activity under compatible conditions. Lysozyme acts on susceptible bacterial peptidoglycan but is not a universal lysis enzyme. DNase may reduce unwanted DNA when RNA is the target, while selective nuclease strategies can support host-depletion workflows. Every nuclease step requires a defined stopping or removal strategy.
Creative Enzymes supplies liquid Proteinase K for mNGS, lyophilized Proteinase K for NGS, recombinant protease K, lysozyme, DNase I, heat-labile dsDNase, and related products. We also support nucleic-acid extraction enzyme-system optimization.
Proteinase K digests proteins and can help release nucleic acids or reduce nuclease activity under compatible conditions. Lysozyme acts on susceptible bacterial peptidoglycan but is not a universal lysis enzyme. DNase may reduce unwanted DNA when RNA is the target, while selective nuclease strategies can support host-depletion workflows. Every nuclease step requires a defined stopping or removal strategy.
Molecular assays begin with release, preservation, and purification of the target nucleic acid. Enzymes may support cell-wall disruption, protein digestion, nuclease-based host depletion, viscosity reduction, or cleanup of unwanted nucleic-acid species. The correct choice depends on organism, specimen, target type, extraction chemistry, and downstream assay. The relevant enzyme must be evaluated in the complete sample-to-result workflow because cofactors, carryover from upstream steps, target abundance, temperature, reaction time, and detection chemistry can change apparent performance.
Product selection should begin with the complete reaction and workflow rather than an isolated activity value. The following components represent practical roles that may be evaluated for molecular sample preparation enzymes development.
| Enzyme or Reagent | Role in the Workflow | Representative Product or Support | Selection Considerations |
|---|---|---|---|
| Proteinase K | Protein digestion and nucleic-acid release | Liquid for mNGS; lyophilized for NGS | Matrix, detergent, temperature, inactivation and nuclease background |
| Lysozyme | Lysis support for susceptible bacterial cell walls | Lysozyme | Organism, wall structure, accessibility and combination lysis |
| DNase I | Removal of unwanted DNA in defined workflows | DNase I formats | Target type, magnesium, stopping method and downstream risk |
| Heat-labile dsDNase | Double-stranded DNA depletion with heat-inactivation option | Heat-labile dsDNase | Specificity, inactivation, residual activity and RNA preservation |
| Nuclease/protease system | Custom host depletion or extraction support | Optimization service | Recovery, bias, inhibitor removal and downstream compatibility |
Sample preparation must address the physical barriers present in the actual specimen. Proteinase K is useful for protein digestion and nuclease reduction in many workflows, but it does not replace mechanical disruption of every tissue or specialized lysis of spores, fungi, or resistant bacteria. Lysozyme targets susceptible peptidoglycan and may assist bacterial lysis, yet species, growth state, and cell-wall structure change response. Detergents, chaotropes, heat, beads, or other enzymes may be required in combination.
The desired analyte also changes the strategy. A DNA workflow may tolerate RNase treatment, while an RNA assay must minimize RNase exposure and may use DNase to reduce genomic background. Cell-free nucleic acids are already fragmented and can be lost through aggressive digestion or purification. For microbial metagenomics, host-depletion conditions should reduce host material without selectively destroying important microorganisms or extracellular target nucleic acid.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
An extraction enzyme can become a downstream inhibitor if it remains active or carries salts, detergents, or storage additives into amplification. Proteinase K may damage polymerases or other proteins if not inactivated or removed. DNase remaining in an RNA preparation can degrade DNA primers or probes under permissive conditions. Conversely, harsh heat treatment used for inactivation can fragment RNA or alter the target. Each handoff should have a defined stop, cleanup, dilution, or sequestration mechanism.
Direct-PCR and extraction-free workflows deliberately accept more matrix carryover. Their apparent simplicity shifts requirements to the polymerase and buffer, which must tolerate inhibitors while maintaining specificity. Sample volume cannot be increased indefinitely because inhibitors may rise faster than target recovery. A matrix-specific input study should identify the range where added specimen improves detection and the point at which inhibition dominates.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
A process control added before lysis can monitor release, extraction, and amplification, but it should resemble the target sufficiently to experience relevant losses. An amplification control added after extraction assesses inhibition without measuring recovery. Negative extraction controls reveal cross-contamination introduced during processing. These controls answer different questions and should not be substituted for one another.
Recovery should be tested across representative specimen variability rather than a single pooled matrix. Relevant comparisons may include organism load, storage time, transport medium, viscosity, blood contamination, freeze-thaw history, and operator technique. For broad microbial assays, taxonomic composition can reveal selective lysis or depletion bias. Release and lot-transition testing should include the complete process response because high protease or nuclease activity on a purified substrate does not guarantee balanced recovery from samples.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
Host-depletion and selective-digestion steps can improve the proportion of informative target reads or copies, but they can also change which targets remain. Intracellular organisms, damaged cells, free nucleic acids, and organisms with different wall structures may respond differently. Method comparison should therefore examine target recovery across representative organism classes and concentration levels, not only the percentage reduction in host DNA. A large decrease in total host material is not beneficial if low-abundance targets are lost or taxonomic composition is distorted.
Document the following elements:
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Potential risks to evaluate include:
Relevant challenge levels and acceptance criteria depend on the intended use, sample matrix, reaction format, instrument, and decision threshold. Performance should be established with the final formulation rather than inferred from individual-component specifications.
Troubleshooting molecular sample preparation enzymes is most efficient when the workflow is divided into sample preparation, enzyme reaction, signal generation, and result interpretation. A positive control and a negative control are necessary, but they may not identify which module failed. Orthogonal measurements and module-specific controls should be selected before changing multiple reagents at once.
| Observation | Possible Causes | Focused Checks |
|---|---|---|
| Internal control is weak in all samples | Matrix carryover or downstream inhibition | Dilute eluate, review wash and drying steps, and use a post-extraction spike |
| Control recovers but target is lost | Incomplete target-specific lysis or selective depletion | Review organism structure, localization, enzyme access, and mechanical disruption |
| RNA target degrades after preparation | RNase exposure or harsh inactivation | Audit reagents, handling time, temperature, and residual nuclease |
| Negative extraction controls are positive | Cross-contamination during batching or aerosol transfer | Separate steps, inspect shared reagents, and trace contamination with process blanks |
A single successful repeat does not confirm the cause of a failure. Once a likely factor is identified, the proposed correction should be challenged across target levels, representative matrices, reagent lots, instruments or devices, operators, and relevant environmental conditions. The final procedure should define valid controls, acceptance criteria, and actions for invalid runs.
Need Help Selecting Molecular Sample Preparation Enzymes?
Share your target, sample type, workflow, detection chemistry, instrument, desired reagent format, current formulation, performance goals, and expected scale with our technical team.
Request Product Selection Support
Q1. Is Proteinase K sufficient for every specimen?
Q2. When is lysozyme useful?
Q3. Why must nuclease inactivation be verified?
Q4. What is host depletion?
Q5. Can extraction be omitted?
Q6. Which controls are useful?
